SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-24-037156
Filing Date
2024-04-29
Accepted
2024-04-29 16:06:45
Documents
16
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K ea0204802-10ka1_allarity.htm   iXBRL 10-K/A 426108
2 CERTIFICATION ea020480201ex31-3_allarity.htm EX-31.3 4209
3 CERTIFICATION ea020480201ex31-4_allarity.htm EX-31.4 4200
  Complete submission text file 0001213900-24-037156.txt   730150

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE allr-20231231.xsd EX-101.SCH 3240
5 XBRL DEFINITION FILE allr-20231231_def.xml EX-101.DEF 17754
6 XBRL LABEL FILE allr-20231231_lab.xml EX-101.LAB 36878
7 XBRL PRESENTATION FILE allr-20231231_pre.xml EX-101.PRE 18907
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0204802-10ka1_allarity_htm.xml XML 7176
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-41160 | Film No.: 24890650
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)